Invenomic Capital Management’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-401,156
Closed -$26.2M 169
2026
Q1
$26.2M Buy
+401,156
New +$29.8M 1.2% 28
2025
Q1
Sell
-320,609
Closed -$21.2M 208
2024
Q4
$21.2M Sell
320,609
-264,274
-45% -$18.5M 1.01% 25
2024
Q3
$40.8M Sell
584,883
-239,302
-29% -$14.4M 2.24% 8
2024
Q2
$43.6M Buy
+824,185
New +$50M 2.12% 7

Other funds holding SOLV

Invenomic Capital Management's SOLV Position: Q2 2026 in Review

Invenomic Capital Management sold out of Solventum (SOLV) in Q2 2026, closing a stake of 401,156 shares — an estimated $26.2M sold.

Invenomic Capital Management first reported a position in SOLV in Q2 2024 and held it in 4 quarters. The position peaked at $43.6M in Q2 2024. 878 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Invenomic Capital Management reported no remaining Solventum position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 401,156 Solventum shares in Q2 2026, an estimated $26.2M.
  • Invenomic Capital Management first reported a position in Solventum in Q2 2024 and held it in 4 quarters.
  • Invenomic Capital Management's Solventum position peaked at $43.6M in Q2 2024.
  • 878 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.